News

Filter

1 to 9 of 26 results

Teva to sue Dr Reddy’s over Copaxone patent infringement

Teva to sue Dr Reddy’s over Copaxone patent infringement

08-08-2014

Global generics leader Teva Pharmaceutical Industries yesterday confirmed that it has received the first…

CopaxoneDr Reddy's LaboratoriesLegalNeurologicalPatentsPharmaceuticalTeva Pharmaceutical IndustriesUSA

Generic pains for AstraZeneca exacerbated by Indian drugmakers

Generic pains for AstraZeneca exacerbated by Indian drugmakers

06-04-2014

Indian generic companies are taking aim at mega blockbusters, and AstraZeneca, the $25.7 billion pharmaceutical…

Asia-PacificAstraZenecaDr Reddy's LaboratoriesFinancialGastro-intestinalsGenericsIndiaMarkets & MarketingNexiumPharmaceuticalPulmicortRanbaxy LaboratoriesRespiratory and PulmonarySymbicortUSAVimovo

Dr Reddy’s sees generics soar due to limited competition

Dr Reddy’s sees generics soar due to limited competition

11-02-2014

India’s second-largest drugmaker Dr Reddy's Laboratories has reported strong third quarter sales of…

Dr Reddy's LaboratoriesFinancialGenericsIndiaPharmaceutical

Galena Biopharma links with and Dr Reddy's for NeuVax in India

14-01-2014

USA-based Galena Biopharma and India’s second-largest drugmaker Dr Reddy's Laboratories have entered…

Asia-PacificDr Reddy's LaboratoriesGalena BioPharmaIndiaLicensingNeuVaxOncologyPharmaceutical

Report: Indian pharma companies’ innovation is increasing but fails to match Europe

10-01-2014

Innovation by Indian pharmaceutical companies has increased over the last few years but has not demonstrated…

CiplaDr Reddy's LaboratoriesIndiaPatentsPharmaceuticalResearch

News briefs: Dr Reddy's launches generic Accutane; Cyprus drug shortages

29-03-2013

Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) says it launched Zenatane (isotretinoin capsules…

AccutaneDermatologicalsDr Reddy's LaboratoriesEuropeGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalZenatane

Dr Reddy's launches Debiopharm's cancer drug Pamorelin LA in India

09-12-2012

Independent Swiss biopharma firm Debiopharm Group announced on Friday that, on December 3, Dr. Reddy's…

Asia-PacificDebiopharmDr Reddy's LaboratoriesLicensingMarkets & MarketingOncologyPamorelinPharmaceutical

India's Dr Reddy's to acquire OctoPlus for $35.7 million

22-10-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds…

Dr Reddy's LaboratoriesGenericsMergers & AcquisitionsOctoPlusPharmaceutical

1 to 9 of 26 results

COMPANY SPOTLIGHT

Menarini

Back to top